DSM has reached agreement to acquire Aland, a Hong Kong-based company producing vitamin C in mainland China. Financial details were not disclosed. Subject to customary conditions, the transaction is expected to close in the next six to nine months. DSM previously announced on 9 April 2014 that it was in exclusive discussions to acquire Aland.
According to the company, acquiring Aland, one of the leading Vitamin C manufacturers in China, allows DSM to further strengthen its position in vitamin C, increasing DSM’s global footprint in vitamins for human nutrition and health, animal nutrition and health and personal care. DSM said that it remains fully committed to its current vitamin C manufacturing facility in Dalry (Scotland, United Kingdom).
Aland was founded in 1990 and has a production facility in Jingjiang, Jiangsu Province in China. In 2013 the company realised net sales of about $90 million in vitamin C with around 1,850 employees.
The transaction excludes Aland’s consumer health activities.
DSM said that it plans to invest in Aland’s production facilities for operational excellence including quality and environmental performance.
